2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
The present invention provides therapeutically effective 2,4,5-trisubstituted imidazole compounds, methods of preparing the same, and compositions comprising the compounds alone or in combination with other agents. The present invention further provides for the use of the compounds as anti-microbial agents. The anti-microbial properties of the compounds include anti-bacterial and/or anti-fungal activity.
1. A compound of the structural formula:
or a salt thereof, wherein:
R4, R5, R6, R7, R8 and R9 are independently selected from hydrogen, halogen, hydroxyl, thiol, lower alkyl, substituted lower alkyl, lower alkenyl, substituted lower alkenyl, lower alkynyl, substituted lower alkynyl, alkylalkenyl, alkyl alkynyl, alkoxy, alkylthio, acyl, aryloxy, amino, amido, carboxyl, aryl, substituted aryl, heterocycle, heteroaryl, substituted heterocycle, heteroalkyl, cycloalkyl, substituted cycloalkyl, alkylcycloalkyl, alkylcycloheteroalkyl, nitro, or cyano;
R10 is H, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, or acyl;
x is CR11;
y is CR12 or N;
z is CR13 or N;
r is CR14 or N;
x′ is CR15;
y′ is CR16 or N;
z′ is CR17 or N;
r′ is CR18 or N; and
R11, R12, R13, R14, R15, R16, R17 and R18 are independently selected from hydrogen, halogen, hydroxyl, thiol, lower alkyl, substituted lower alkyl, lower alkenyl, lower alkynyl, alkylalkenyl, alkyl alkynyl, alkoxy, alkylthio, acyl, aryloxy, amino, amido, carboxyl, aryl, substituted aryl, heterocycle, heteroaryl,
substituted heterocycle, heteroalkyl, cycloalkyl, substituted cycloalkyl, alkylcycloalkyl, alkylcycloheteroalkyl, nitro, or cyano;
wherein at least one of y, z, r, y′, z′ or r′ is N.
2. The compound according to claim 1 , wherein:
x is CR11;
y is CR12;
z is CR13;
r is N;
x′ is CR15;
y′ is CR16;
z′ is CR17; and
r′ is N.
3. The compound according to claim 1 , wherein:
R11, R12, R13, R15, R16 and R17 are independently hydrogen or halogen.
4. The compound according to claim 1 , wherein:
R11, R12, R13, R15, R16 and R17 are each hydrogen.
5. The compound according to claim 1 , wherein:
R5, R6, R7, R8, and R9 are independently hydrogen, halogen, lower alkyl, amino, carboxyl, or nitro.
6. The compound according to claim 1 , wherein:
R5, R6, R7, R8, and R9 are independently hydrogen, halogen, lower alkyl or carboxyl.
7. The compound according to claim 1 , wherein:
R5, R6, R7, R8, and R9 are independently hydrogen, halogen or lower alkyl.
8. The compound according to claim 1 , wherein:
R6 is hydrogen or halogen;
R9 is hydrogen or lower alkyl; and
R5, R7, R8 and R10 are each hydrogen.
9. The compound according to claim 1 , wherein:
R4 is hydrogen or acyl.
10. The compound according to claim 1 , wherein:
R4 is hydrogen.
11. The compound according to claim 1 , wherein:
x is CR11;
y is CR12;
z is CR13;
r is N;
x′ is CR15;
y′ is CR16;
z′ is CR17;
r′ is N;
R11, R12, R13, R15, R16, and R17 are each hydrogen;
R5, R6, R7, R8, and R9 are independently hydrogen, halogen or lower alkyl, and
R4 is hydrogen or acyl.
12. The compound according to claim 11 , wherein:
R4 is hydrogen.
13. The compound according to claim 1 , wherein:
x is CR11;
y is CR12;
z is CR13;
r is N;
x′ is CR15;
y′ is CR16;
z′ is CR17;
r′ is N;
R11, R12, R13, R15, R16, and R17 are each hydrogen;
R6 is hydrogen or halogen;
R9 is hydrogen or lower alkyl;
R5, R7, R8 and R10 are each hydrogen, and
R4 is hydrogen or acyl.
14. The compound according to claim 13 , wherein:
R4 is hydrogen.
15. A pharmaceutical composition comprising a compound according to claim 1 and a pharmaceutically acceptable carrier or diluent.